Healthy Big Data for Biomakers

Pharmaceuticals have been on the tabloids lately due in part for infamous company price gouging but today 3 firms are uniting to make their contributions by analyze data of healthy adult volunteers.  By studying health data patients, it can used to compare/contrast other patient stratification in with a global footprint and perhaps accelerate innovation of other drugs and discovery.  Though the initial focus on therapeutic areas, the power of big data and analytics is contagious.  The 3 biomakers are Astellas, Daiichi Sankyo, and Takeda.
Article Source: The Financial